Answer Happy

Amy Dyken, controller at Splish Pharmaceutical
Industries, a public company, is currently preparing the
calculation for basic and diluted earnings per share and the
related disclosure for Splish’s financial statements. Below is
selected financial information for the fiscal year ended June 30,
2020.
Splish Pharmaceutical Industries
Selected Balance Sheet Information
June 30, 2020
$990,000
5,080,000
6,120,000
$12,190,000
$1,187,500
1,000,000
3,920,000
5,880,000
$11,987,500
The following transactions have also occurred at Splish.
For the fiscal year ended June 30, 2020, calculate the following
for Splish Pharmaceutical
Industries. (Round answers to 2 decimal places,
e.g. $2.45.)

(a) Basic earnings per share.
$
(b) Diluted earnings per share.